The company has been granted patents by South Korea, China & Canada, that will be valid through 2029, 2029 and 2031 respectively, for the treatment of neurodegenerative diseases.
first published: Sep 4, 2014 02:47 pm
A collection of the most-viewed Moneycontrol videos.

Meesho's Rs 5,421 Cr IPO Kicks Off| Post-IPO Playbook, Profitability Path & More| IPO Watch Live

Can Nifty Hold Above 26,000 Amid Currency Jitters? Meesho IPO Opens | Opening Bell Live

Nifty Struggles Below 26,100 On Weekly F&O Expiry As Rupee Hits New Low| Closing Bell Live

Will Rupee Slide & Expiry Day Caution Keep Nifty Bulls On The Back Foot? | Opening Bell Live
You are already a Moneycontrol Pro user.

